{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T14:06:13Z","timestamp":1793541973469,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.ygyno.2009.03.027","type":"journal-article","created":{"date-parts":[[2009,4,30]],"date-time":"2009-04-30T07:34:10Z","timestamp":1241076850000},"page":"94-98","source":"Crossref","is-referenced-by-count":53,"title":["Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer"],"prefix":"10.1016","volume":"114","author":[{"given":"Krystine","family":"Lupe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice S.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A.","family":"Harle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alex","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2009.03.027_bib1","unstructured":"SEER Cancer Statistics Review, 1975\u20132005, National Cancer Institute. Bethesda, MD (seer.cancer.gov\/publications\/survival\/surv_corpus_uteri.pdf)."},{"key":"10.1016\/j.ygyno.2009.03.027_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/gyno.1999.5569","article-title":"FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy","volume":"75","author":"Nelson","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/gyno.2001.6157","article-title":"Analysis of FIGO stage IIIC endometrial cancer patients","volume":"81","author":"McMeekin","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib4","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1002\/1097-0142(19930601)71:11<3697::AID-CNCR2820711137>3.0.CO;2-U","article-title":"Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence","volume":"71","author":"Greven","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2009.03.027_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0360-3016(89)90367-2","article-title":"Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implications","volume":"7","author":"Greven","year":"1989","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2009.03.027_bib6","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ijrobp.2007.02.003","article-title":"Analysis of prognostic factors and patterns of recurrence inpatients with pathologic stage III endometrial cancer","volume":"68","author":"Patel","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2009.03.027_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study","volume":"24","author":"Randall","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib8","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0360-3016(01)01566-8","article-title":"Significant pelvic recurrence in high-risk pathologic stage I\u2013IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy","volume":"50","author":"Mundt","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2009.03.027_bib9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib10","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib11","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib12","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1200\/JCO.2001.19.20.4048","article-title":"Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study","volume":"19","author":"Hoskins","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1525-1438.2007.01094.x","article-title":"Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up","volume":"18","author":"Sorbe","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2009.03.027_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1447-0756.2006.00405.x","article-title":"Paclitaxel\/carboplatin versus cyclophosphamide\/adriamycin\/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma","volume":"32","author":"Hidaka","year":"2006","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ygyno.2009.03.027_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ygyno.2006.03.019","article-title":"Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study","volume":"03","author":"Sovak","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib16","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.ajog.2004.12.032","article-title":"Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer","volume":"92","author":"Akram","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ygyno.2008.01.028","article-title":"Carboplatin and paclitaxel in advanced or metastatic endometrial cancer","volume":"109","author":"Pectasides","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2006.08.006","article-title":"Adjuvant paclicataxel and carbpoblatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach","volume":"67","author":"Lupe","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2009.03.027_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1525-1438.1994.04050315.x","article-title":"Neither toxicity nor dose intensity of carboplatin is affected by glomerular filtration rate versus body surface area dose calculation in gynecologic malignancy","volume":"4","author":"Tonkin","year":"1994","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2009.03.027_bib20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ijrobp.2004.06.253","article-title":"Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies","volume":"61","author":"Wong","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2009.03.027_bib21","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events Version 3. 2006. Ref Type: Report"},{"key":"10.1016\/j.ygyno.2009.03.027_bib22","unstructured":"RTOG\/EORTC late radiation morbidity scoring scheme (1999\/CTC VERSION 2.0)."},{"key":"10.1016\/j.ygyno.2009.03.027_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ygyno.2004.06.041","article-title":"Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin\/cisplatin chemotherapy for advanced stage endometrial cancer: a Gynecologic Oncology Group trial","volume":"95","author":"Soper","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2004.02.008","article-title":"Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III\u2013IV endometrial cancer patients","volume":"93","author":"Bruzzone","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2004.09.022","article-title":"A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-GSF) support followed by radiotherapy in patients with \u201chigh-risk\u201d endometrial cancer","volume":"96","author":"Duska","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2006.02.007","article-title":"Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin\/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer","volume":"103","author":"Greven","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2007.06.014","article-title":"The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer","volume":"71","author":"Alvarez Secord","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib28","unstructured":"Womens Cancer Network, Gynecologic Cancer Foundation. Study GOG-209: Clinical Trials and Research. Trial of Doxorubicin\/Cisplatin\/Paclitaxel and G-CSF vs Carboplatin\/Paclitaxel in Patients with Stage III & IV or Recurrent Endometrial Cancer."},{"key":"10.1016\/j.ygyno.2009.03.027_bib29","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.2004.07.184","article-title":"Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study","volume":"22","author":"Fleming","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib30","unstructured":"PORTEC 3. (http:\/\/www.trialregister.nl\/trialreg\/admin\/rctview.asp?TC=729) Access date: October 19, 2008."},{"key":"10.1016\/j.ygyno.2009.03.027_bib31","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1200\/JCO.2004.11.154","article-title":"Her-2\/neu overexpression and amplification in uterine papillary serous carcinoma","volume":"22","author":"Slomovitz","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.03.027_bib32","doi-asserted-by":"crossref","unstructured":"Oza A, Eisenhauer E, Elit L et al. Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148. J Clin Oncol. 2008 Jun 30;.[Electronic publication ahead of print].","DOI":"10.1200\/JCO.2007.15.8808"},{"key":"10.1016\/j.ygyno.2009.03.027_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1525-1438.2007.00958.x","article-title":"Loss of phosphates and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of rapamycin are associated with progesterone refractory endometrial hyperplasia","volume":"18","author":"Milam","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2009.03.027_bib34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2006.10.007","article-title":"Economopoulos. Systemic therapy in metastatic or recurrent endometrial cancer","volume":"33","author":"Pectasides","year":"2007","journal-title":"Cancer Treat. Rev."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809002029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809002029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T15:19:57Z","timestamp":1558279197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825809002029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0090825809002029"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2009.03.027","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1162360.622860","asserted-by":"object"}]},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}